Clinical Trial

OBSERVATIONAL STUDY ON VIRAL SHEDDING AND IMMUNOLOGICAL RESPONSE OF OROPOUCHE VIRUS

Study acronym: OROVIMM
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 18, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a single-center observational study, whose primary objective is to describe the immune response to Oropouche Virus (OROV) during the study period and the duration of viral RNA shedding, only for sequential samples, by RT-PCR in different matrices.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-18.
Trial Details
NCT Number NCT06892015
Lead Sponsor IRCCS Sacro Cuore Don Calabria di Negrar
Conditions Oropouche Infection
Enrollment 30 participants
Start Date 2024-12-19
Primary Completion 2026-04 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-05-18